GH Q2 2025 Earnings — Guardant Health, Inc. Revenue & Financial Results | Market Cap Arena

GHGuardant Health, Inc.

$12B

Q2 2025 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$232M+30.9% YoY

Gross Profit

$151M65.0% margin

Operating Income

-$106M-45.9% margin

Net Income

-$100M-43.0% margin

EPS (Diluted)

$-0.80

QoQ Revenue Growth

+14.1%

Cash Flow

Operating Cash Flow

-$60M

Free Cash Flow

-$66M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$1.3B

Total Liabilities

$1.6B

Stockholders' Equity

-$305M

Cash & Equivalents

$629M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$232M	$177M	+30.9%
Gross Profit	$151M	$105M	+44.0%
Operating Income	-$106M	-$101M	-5.8%
Net Income	-$100M	-$103M	+2.7%

Revenue Segments

Oncology

$159M68%

Biopharma & Data

$56M24%

Screening

$15M6%

Licensing & Other

$3M1%

Geographic Segments

UNITED STATES

$217M93%

Non-US

$15M7%